Literature DB >> 361570

Intraintestinal toxin in infant mice challenged intragastrically with Clostridium botulinum spores.

H Sugiyama, D C Mills.   

Abstract

Conventionally raised suckling mice were injected intragastrically with 10(5) spores of a Clostridium botulinum type A culture. Botulism was not observed, but 80% or more of mice challenged when 8 to 11 days old had botulinum toxin in the large intestine 3 days later. Mice younger than 7 days or older than 15 days were resistant to the challenge. When in vivo toxin production was started by spores given to 9-day-old mice, toxin was present in the intestine at 1 through 7 days postchallenge but with greatest consistency between 1 and 4 days. Total toxin in an intestine ranged up to 1,920 50% lethal doses as titrated intraperitoneally in adult mice. The dose infecting 50% of a group of 9-day-old mice was 700 (95% confidence limits of 170 to 3,000) spores per animal. Toxin was formed in the lumen of the large intestine; it was not associated with the ileum. Injection of 10(5) spores intraperitoneally into 9-day-old mice resulted in toxin production in the large intestines of 30% of the test animals.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 361570      PMCID: PMC421957          DOI: 10.1128/iai.21.1.59-63.1978

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  [Neutralization of toxin introduced with antiserum by enteral route and formed in the gastrointestinal tract during experimental Clostridium botulinum A toxin intoxication].

Authors:  L M SHVEDOV
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  1959-01

2.  The absorption of Clostridium botulinum type A toxin from the alimentary canal.

Authors:  A J MAY; B C WHALER
Journal:  Br J Exp Pathol       Date:  1958-06

3.  Intestinal absorption of botulinum toxins of different molecular sizes in rats.

Authors:  S Sugii; I Ohishi; G Sakaguchi
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

Review 4.  Microbial ecology of the gastrointestinal tract.

Authors:  D C Savage
Journal:  Annu Rev Microbiol       Date:  1977       Impact factor: 15.500

5.  Possible origin of the high incidence of Clostridium botulinum type E in an inland bay (Green Bay of Lake Michigan).

Authors:  T L Bott; J Johnson; E M Foster; H Sugiyama
Journal:  J Bacteriol       Date:  1968-05       Impact factor: 3.490

6.  Growth potential of Clostridium botulinum in fresh mushrooms packaged in semipermeable plastic film.

Authors:  H Sugiyama; K H Yang
Journal:  Appl Microbiol       Date:  1975-12

7.  Infant botulism. Epidemiological, clinical, and laboratory aspects.

Authors:  S S Arnon; T F Midura; S A Clay; R M Wood; J Chin
Journal:  JAMA       Date:  1977-05-02       Impact factor: 56.272

8.  Pathogenesis of Clostridium botulinum type A: release of toxin from C. botulinum spores in vitro by leucocytes.

Authors:  J B Suzuki; R R Booth; N Grecz
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1970-09

9.  Infant botulism. Identification of Clostridium botulinum and its toxins in faeces.

Authors:  T F Midura; S S Arnon
Journal:  Lancet       Date:  1976-10-30       Impact factor: 79.321

  9 in total
  11 in total

Review 1.  Update: infant botulism.

Authors:  T F Midura
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

Review 2.  Clostridium botulinum neurotoxin.

Authors:  H Sugiyama
Journal:  Microbiol Rev       Date:  1980-09

3.  Perturbation to Cholesterol at the Neuromuscular Junction Confers Botulinum Neurotoxin A Sensitivity to Neonatal Mice.

Authors:  Baskaran Thyagarajan; Joseph G Potian; Joseph J McArdle; Padmamalini Baskaran
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

4.  Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants.

Authors:  D C Mills; T F Midura; S S Arnon
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

5.  Susceptibility to enteric botulinum colonization of antibiotic-treated adult mice.

Authors:  D H Burr; H Sugiyama
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

6.  Botulism in metronidazole- treated conventional adult mice challenged orogastrically with spores of Clostridium botulinum type A or B.

Authors:  Y Wang; H Sugiyama
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

7.  A case of infant botulism associated with honey feeding in Italy.

Authors:  L Fenicia; A M Ferrini; P Aureli; M Pocecco
Journal:  Eur J Epidemiol       Date:  1993-11       Impact factor: 8.082

8.  Microbial ecological basis of infant botulism as studied with germfree mice.

Authors:  L J Moberg; H Sugiyama
Journal:  Infect Immun       Date:  1979-08       Impact factor: 3.441

9.  The rat as an animal model for infant botulism.

Authors:  L J Moberg; H Sugiyama
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Clostridium tetani growth and toxin production in the intestines of germfree rats.

Authors:  C L Wells; E Balish
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.